Met Life Investment Management, LLC Codexis, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,160 shares of CDXS stock, worth $198,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,160
Previous 17,591
162.41%
Holding current value
$198,949
Previous $54,000
307.41%
% of portfolio
0.0%
Previous 0.0%
Shares
42 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
62.4MCall Options Held
67.9KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$38.1 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$34.9 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$29.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$19.2 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$12.9 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $282M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...